Enovis (ENOV) Net Cash Flow Growth (1y) (2011 - 2026)
Enovis (ENOV) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 76.43% |
| 10 | Enovis | 1.61 Bn | 1.58 Bn | 365.49 Mn | 71.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 71.43% |
| Dec 31, 2025 | -74.55% |
| Oct 3, 2025 | -107.32% |
| Jul 4, 2025 | 113.53% |
| Apr 4, 2025 | -135.77% |
| Dec 31, 2024 | -12.39% |
| Sep 27, 2024 | -2,568.97% |
| Jun 28, 2024 | -389.78% |
| Mar 29, 2024 | 1,356.87% |
| Dec 31, 2023 | 137.67% |
| Sep 29, 2023 | 100.51% |
| Jun 30, 2023 | 101.89% |
| Mar 31, 2023 | 95.98% |
| Dec 31, 2022 | -105.79% |
| Sep 30, 2022 | -134.72% |
| Jul 1, 2022 | 19.43% |
| Apr 1, 2022 | -109.10% |
| Dec 31, 2021 | 1,606.86% |
| Oct 1, 2021 | 19,157.40% |
| Jul 2, 2021 | -132.90% |